Urology Times Innovation Celebration: Expert Insights

Interview articles featuring in-depth analysis of each innovation from urology experts.

How BCG became the standard of care for bladder cancer

March 16th 2022

In this installment of Urology Times' 50th Anniversary Innovation Celebration, Sam S. Chang, MD, MBA, discusses the critical role that BCG has played in managing bladder cancer, and how the BCG shortage continues to evolve.

“A wild and wooly time”: Extracorporeal shock wave lithotripsy for kidney stones

March 23rd 2022

In this installment of Urology Times' 50th Anniversary Innovation Celebration, James E. Lingeman, MD, discusses the development of extracorporeal shock wave lithotripsy for the treatment of kidney stones.

Treatment of hypoactive sexual desire disorder: More treatments bolster clinicians’ armamentarium

March 30th 2022

In this installment of Urology Times' 50th Anniversary Innovation Celebration, Rachel S. Rubin, MD, discusses the evolution in the treatment of female hypoactive sexual desire disorder.

Dr. J. Stephen Jones highlights the emergence and evolution of cryotherapy in urology

April 6th 2022

"Throughout the years, I've said it's not hard to destroy tissue; it's hard to destroy tissue without destroying other things around [the cancer]," says J. Stephen Jones, MD, FACS.

How intralesional therapies have changed the treatment of Peyronie’s disease

April 13th 2022

"Now, men have the option to seek out something minimally invasive before surgical options are breached," says Denise Asafu-Adjei, MD, MPH.

Radiation therapy for prostate cancer continues to evolve

April 20th 2022

In this installment of our 50th Anniversary Innovation Celebration, Anthony Zietman, MD, discusses the development of radiation therapy for prostate cancer.

Beta 3 agonists: A “much-needed alternative” for patients with OAB

April 27th 2022

In this installment of Urology Times' 50th Anniversary Innovation Celebration, Ekene A. Enemchukwu, MD, MPH, discusses the development of β3 agonists for the treatment of overactive bladder.

microTESE revolutionizes surgical management of male factor infertility

May 4th 2022

In this installment of the Urology Times' 50th Anniversary Innovation Celebration, Denise Asafu-Adjei, MD, MPH, discusses the development of microsurgical testicular sperm extraction.

Anatomic radical prostatectomy transforms prostate surgery

May 11th 2022

In this interview, Christopher L. Amling, MD, FACS, discusses the development of anatomic radical prostatectomy and how the technique transformed the surgical treatment of prostate cancer.

Sipuleucel-T: An innovative immunotherapy option for metastatic castration-resistant prostate cancer

May 19th 2022

In this installment of the Urology Times' 50th Anniversary Innovation Celebration, Kelvin A. Moses, MD, PhD, discusses the prostate cancer immunotherapy treatment sipuleucel-T (Provenge).